OR | 95% CI | P | |
---|---|---|---|
Age (vs < 50) | |||
50–64 | 0.862 | 0.774–0.959 | 0.006 |
65–69 | 0.680 | 0.603–0.767 | < 0.001 |
70–74 | 0.670 | 0.595–0.754 | < 0.001 |
75–79 | 0.544 | 0.483–0.613 | < 0.001 |
80–84 | 0.424 | 0.375–0.479 | < 0.001 |
85 and over | 0.179 | 0.156–0.205 | < 0.001 |
Female sex (vs male) | 0.745 | 0.705–0.788 | < 0.001 |
STEMI as index event (vs NSTEMI) | 2.281 | 2.165–2.402 | < 0.001 |
Atrial fibrillation | 0.746 | 0.686–0.811 | < 0.001 |
Diabetes mellitus | 0.777 | 0.732–0.825 | < 0.001 |
Chronic renal failure | 0.585 | 0.477–0.718 | < 0.001 |
Dementia/Alzheimer’s disease | 0.195 | 0.153–0.247 | < 0.001 |
Ischemic stroke or TIA | 0.467 | 0.417–0.523 | < 0.001 |
Major bleedings | 0.565 | 0.496–0.643 | < 0.001 |
Hypertension | 0.833 | 0.758–0.915 | < 0.001 |
Hyperlipidemia | 1.886 | 1.760–2.022 | < 0.001 |
Congestive heart failure | 0.527 | 0.488–0.569 | < 0.001 |
Severe liver disease | 0.739 | 0.444–1.231 | 0.245 |
COPD | 0.582 | 0.501–0.677 | < 0.001 |
Malignancy | 0.691 | 0.618–0.771 | < 0.001 |